APO Research

APO RESEARCH · REPORT

Integrated Multi-Omics Services

Selected research

Industry Growth & Trends

Global Integrated Multi-Omics Services Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Integrated Multi-Omics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Integrated Multi-Omics Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Integrated Multi-Omics Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrated Multi-Omics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Integrated Multi-Omics Services market include Azenta Life Sciences, Eurofins, Source BioScience, Psomagen, Tempus, Evotec, Crown Bioscience, Sapient and Bruker Spatial Biology CRO Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Integrated Multi-Omics Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Integrated Multi-Omics Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Integrated Multi-Omics Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Integrated Multi-Omics Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Integrated Multi-Omics Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Integrated Multi-Omics Services Market by Company

Azenta Life Sciences

Eurofins

Source BioScience

Psomagen

Tempus

Evotec

Crown Bioscience

Sapient

Bruker Spatial Biology CRO Services

Advanced Cell Diagnostics (ACD)

Panome Bio

RayBiotech

Metware Biotechnology

HaploX

Creative Proteomics

CD Genomics

Omics Empower

Cmbio

Dalton Bioanalytics

General Metabolics

Signios Bio

Source Genomics

Genechem

BGI Genomics

OE Biotech

BMKGENE

Majorbio

Wayen Biotechnologies

Integrated Multi-Omics Services Segment by Type

Dual-Omics Integration Services

Triple-Omics Integration Services

Quadruple & Above Multi-Omics Integration Services

Integrated Multi-Omics Services Segment by Application

Disease Research

Precision Medicine

Crop Breeding

Environmental Microbial Monitoring

Others

Integrated Multi-Omics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrated Multi-Omics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrated Multi-Omics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrated Multi-Omics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Integrated Multi-Omics Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Integrated Multi-Omics Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Integrated Multi-Omics Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Integrated Multi-Omics Services Market Share by Region (2021-2026) Table 4. Global Integrated Multi-Omics Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Integrated Multi-Omics Services Market Share by Region (2027-2032) Table 6. Global Integrated Multi-Omics Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Integrated Multi-Omics Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Integrated Multi-Omics Services Market Size Share by Type (2021-2026) Table 9. Global Integrated Multi-Omics Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Integrated Multi-Omics Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Integrated Multi-Omics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Integrated Multi-Omics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Integrated Multi-Omics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Integrated Multi-Omics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Integrated Multi-Omics Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Integrated Multi-Omics Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Integrated Multi-Omics Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Integrated Multi-Omics Services Market Size Share by Application (2021-2026) Table 24. Global Integrated Multi-Omics Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Integrated Multi-Omics Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Integrated Multi-Omics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Integrated Multi-Omics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Integrated Multi-Omics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Integrated Multi-Omics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Integrated Multi-Omics Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Integrated Multi-Omics Services Industry Trends Table 37. Integrated Multi-Omics Services Industry Drivers Table 38. Integrated Multi-Omics Services Industry Opportunities and Challenges Table 39. Integrated Multi-Omics Services Industry Restraints Table 40. Global Integrated Multi-Omics Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Integrated Multi-Omics Services Revenue Market Share by Company (2021-2026) Table 42. Global Integrated Multi-Omics Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Integrated Multi-Omics Services Key Company Headquarters & Area Served Table 44. Global Integrated Multi-Omics Services Company, Product Type & Application Table 45. Global Integrated Multi-Omics Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Integrated Multi-Omics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Azenta Life Sciences Company Information Table 49. Azenta Life Sciences Business Overview Table 50. Azenta Life Sciences Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Azenta Life Sciences Integrated Multi-Omics Services Product Portfolio Table 52. Azenta Life Sciences Recent Development Table 53. Eurofins Company Information Table 54. Eurofins Business Overview Table 55. Eurofins Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eurofins Integrated Multi-Omics Services Product Portfolio Table 57. Eurofins Recent Development Table 58. Source BioScience Company Information Table 59. Source BioScience Business Overview Table 60. Source BioScience Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Source BioScience Integrated Multi-Omics Services Product Portfolio Table 62. Source BioScience Recent Development Table 63. Psomagen Company Information Table 64. Psomagen Business Overview Table 65. Psomagen Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Psomagen Integrated Multi-Omics Services Product Portfolio Table 67. Psomagen Recent Development Table 68. Tempus Company Information Table 69. Tempus Business Overview Table 70. Tempus Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Tempus Integrated Multi-Omics Services Product Portfolio Table 72. Tempus Recent Development Table 73. Evotec Company Information Table 74. Evotec Business Overview Table 75. Evotec Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Evotec Integrated Multi-Omics Services Product Portfolio Table 77. Evotec Recent Development Table 78. Crown Bioscience Company Information Table 79. Crown Bioscience Business Overview Table 80. Crown Bioscience Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Crown Bioscience Integrated Multi-Omics Services Product Portfolio Table 82. Crown Bioscience Recent Development Table 83. Sapient Company Information Table 84. Sapient Business Overview Table 85. Sapient Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sapient Integrated Multi-Omics Services Product Portfolio Table 87. Sapient Recent Development Table 88. Bruker Spatial Biology CRO Services Company Information Table 89. Bruker Spatial Biology CRO Services Business Overview Table 90. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product Portfolio Table 92. Bruker Spatial Biology CRO Services Recent Development Table 93. Advanced Cell Diagnostics (ACD) Company Information Table 94. Advanced Cell Diagnostics (ACD) Business Overview Table 95. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product Portfolio Table 97. Advanced Cell Diagnostics (ACD) Recent Development Table 98. Panome Bio Company Information Table 99. Panome Bio Business Overview Table 100. Panome Bio Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Panome Bio Integrated Multi-Omics Services Product Portfolio Table 102. Panome Bio Recent Development Table 103. RayBiotech Company Information Table 104. RayBiotech Business Overview Table 105. RayBiotech Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. RayBiotech Integrated Multi-Omics Services Product Portfolio Table 107. RayBiotech Recent Development Table 108. Metware Biotechnology Company Information Table 109. Metware Biotechnology Business Overview Table 110. Metware Biotechnology Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Metware Biotechnology Integrated Multi-Omics Services Product Portfolio Table 112. Metware Biotechnology Recent Development Table 113. HaploX Company Information Table 114. HaploX Business Overview Table 115. HaploX Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. HaploX Integrated Multi-Omics Services Product Portfolio Table 117. HaploX Recent Development Table 118. Creative Proteomics Company Information Table 119. Creative Proteomics Business Overview Table 120. Creative Proteomics Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Creative Proteomics Integrated Multi-Omics Services Product Portfolio Table 122. Creative Proteomics Recent Development Table 123. CD Genomics Company Information Table 124. CD Genomics Business Overview Table 125. CD Genomics Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. CD Genomics Integrated Multi-Omics Services Product Portfolio Table 127. CD Genomics Recent Development Table 128. Omics Empower Company Information Table 129. Omics Empower Business Overview Table 130. Omics Empower Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Omics Empower Integrated Multi-Omics Services Product Portfolio Table 132. Omics Empower Recent Development Table 133. Cmbio Company Information Table 134. Cmbio Business Overview Table 135. Cmbio Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Cmbio Integrated Multi-Omics Services Product Portfolio Table 137. Cmbio Recent Development Table 138. Dalton Bioanalytics Company Information Table 139. Dalton Bioanalytics Business Overview Table 140. Dalton Bioanalytics Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Dalton Bioanalytics Integrated Multi-Omics Services Product Portfolio Table 142. Dalton Bioanalytics Recent Development Table 143. General Metabolics Company Information Table 144. General Metabolics Business Overview Table 145. General Metabolics Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. General Metabolics Integrated Multi-Omics Services Product Portfolio Table 147. General Metabolics Recent Development Table 148. Signios Bio Company Information Table 149. Signios Bio Business Overview Table 150. Signios Bio Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Signios Bio Integrated Multi-Omics Services Product Portfolio Table 152. Signios Bio Recent Development Table 153. Source Genomics Company Information Table 154. Source Genomics Business Overview Table 155. Source Genomics Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Source Genomics Integrated Multi-Omics Services Product Portfolio Table 157. Source Genomics Recent Development Table 158. Genechem Company Information Table 159. Genechem Business Overview Table 160. Genechem Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Genechem Integrated Multi-Omics Services Product Portfolio Table 162. Genechem Recent Development Table 163. BGI Genomics Company Information Table 164. BGI Genomics Business Overview Table 165. BGI Genomics Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. BGI Genomics Integrated Multi-Omics Services Product Portfolio Table 167. BGI Genomics Recent Development Table 168. OE Biotech Company Information Table 169. OE Biotech Business Overview Table 170. OE Biotech Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. OE Biotech Integrated Multi-Omics Services Product Portfolio Table 172. OE Biotech Recent Development Table 173. BMKGENE Company Information Table 174. BMKGENE Business Overview Table 175. BMKGENE Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. BMKGENE Integrated Multi-Omics Services Product Portfolio Table 177. BMKGENE Recent Development Table 178. Majorbio Company Information Table 179. Majorbio Business Overview Table 180. Majorbio Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Majorbio Integrated Multi-Omics Services Product Portfolio Table 182. Majorbio Recent Development Table 183. Wayen Biotechnologies Company Information Table 184. Wayen Biotechnologies Business Overview Table 185. Wayen Biotechnologies Integrated Multi-Omics Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. Wayen Biotechnologies Integrated Multi-Omics Services Product Portfolio Table 187. Wayen Biotechnologies Recent Development Table 188. North America Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. North America Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million) Table 190. North America Integrated Multi-Omics Services Market Share by Country (2021-2026) Table 191. North America Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. North America Integrated Multi-Omics Services Market Share Forecast by Country (2027-2032) Table 193. Europe Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Europe Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million) Table 195. Europe Integrated Multi-Omics Services Market Share by Country (2021-2026) Table 196. Europe Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Europe Integrated Multi-Omics Services Market Share Forecast by Country (2027-2032) Table 198. Asia-Pacific Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Asia-Pacific Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million) Table 200. Asia-Pacific Integrated Multi-Omics Services Market Share by Country (2021-2026) Table 201. Asia-Pacific Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Asia-Pacific Integrated Multi-Omics Services Market Share Forecast by Country (2027-2032) Table 203. Latin America Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Latin America Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million) Table 205. Latin America Integrated Multi-Omics Services Market Share by Country (2021-2026) Table 206. Latin America Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Latin America Integrated Multi-Omics Services Market Share Forecast by Country (2027-2032) Table 208. Middle East & Africa Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Middle East & Africa Integrated Multi-Omics Services Market Size by Country (2021-2026) & (US$ Million) Table 210. Middle East & Africa Integrated Multi-Omics Services Market Share by Country (2021-2026) Table 211. Middle East & Africa Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Middle East & Africa Integrated Multi-Omics Services Market Share Forecast by Country (2027-2032) Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Integrated Multi-Omics Services Product Image Figure 3. Global Integrated Multi-Omics Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Integrated Multi-Omics Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Integrated Multi-Omics Services Market Share by Region: 2025 VS 2032 Figure 6. Global Integrated Multi-Omics Services Market Share by Region (2021-2032) Figure 7. North America Integrated Multi-Omics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Integrated Multi-Omics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Integrated Multi-Omics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Integrated Multi-Omics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Integrated Multi-Omics Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Dual-Omics Integration Services Image Figure 13. Global Dual-Omics Integration Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Triple-Omics Integration Services Image Figure 15. Global Triple-Omics Integration Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Quadruple & Above Multi-Omics Integration Services Image Figure 17. Global Quadruple & Above Multi-Omics Integration Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Integrated Multi-Omics Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Integrated Multi-Omics Services Market Share by Type 2025 VS 2032 Figure 20. North America Integrated Multi-Omics Services Market Size Share by Type (2021-2032) Figure 21. Europe Integrated Multi-Omics Services Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Integrated Multi-Omics Services Market Size Share by Type (2021-2032) Figure 23. Latin America Integrated Multi-Omics Services Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Integrated Multi-Omics Services Market Size Share by Type (2021-2032) Figure 25. Disease Research Image Figure 26. Global Disease Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Precision Medicine Image Figure 28. Global Precision Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Crop Breeding Image Figure 30. Global Crop Breeding Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Environmental Microbial Monitoring Image Figure 32. Global Environmental Microbial Monitoring Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Integrated Multi-Omics Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Integrated Multi-Omics Services Market Share by Application 2025 VS 2032 Figure 37. North America Integrated Multi-Omics Services Market Size Share by Application (2021-2032) Figure 38. Europe Integrated Multi-Omics Services Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Integrated Multi-Omics Services Market Size Share by Application (2021-2032) Figure 40. Latin America Integrated Multi-Omics Services Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Integrated Multi-Omics Services Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Integrated Multi-Omics Services Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Integrated Multi-Omics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Integrated Multi-Omics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Integrated Multi-Omics Services Market Share by Country (2021-2032) Figure 47. Europe Integrated Multi-Omics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Integrated Multi-Omics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Integrated Multi-Omics Services Market Share by Country (2021-2032) Figure 50. Asia-Pacific Integrated Multi-Omics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Integrated Multi-Omics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Integrated Multi-Omics Services Market Share by Country (2021-2032) Figure 53. Latin America Integrated Multi-Omics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Integrated Multi-Omics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Integrated Multi-Omics Services Market Share by Country (2021-2032) Figure 56. Middle East & Africa Integrated Multi-Omics Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Integrated Multi-Omics Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Integrated Multi-Omics Services Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Dual-Omics Integration Services
  • Triple-Omics Integration Services
  • Quadruple & Above Multi-Omics Integration Services
Applications
  • Disease Research
  • Precision Medicine
  • Crop Breeding
  • Environmental Microbial Monitoring
  • Others
Companies covered
  • Azenta Life Sciences
  • Eurofins
  • Source BioScience
  • Psomagen
  • Tempus
  • Evotec
  • Crown Bioscience
  • Sapient
  • Bruker Spatial Biology CRO Services
  • Advanced Cell Diagnostics (ACD)
  • Panome Bio
  • RayBiotech
  • Metware Biotechnology
  • HaploX
  • Creative Proteomics
  • CD Genomics
  • Omics Empower
  • Cmbio
  • Dalton Bioanalytics
  • General Metabolics
  • Signios Bio
  • Source Genomics
  • Genechem
  • BGI Genomics
  • OE Biotech
  • BMKGENE
  • Majorbio
  • Wayen Biotechnologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Integrated Multi-Omics Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Integrated Multi-Omics Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Integrated Multi-Omics Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Integrated Multi-Omics Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Integrated Multi-Omics Services Market Size (2021-2032)
  8. 1.5.1 North America Integrated Multi-Omics Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Integrated Multi-Omics Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Integrated Multi-Omics Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Integrated Multi-Omics Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Integrated Multi-Omics Services Market Size Growth Rate (2021-2032)
2 Integrated Multi-Omics Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Dual-Omics Integration Services
  3. 2.1.2 Triple-Omics Integration Services
  4. 2.1.3 Quadruple & Above Multi-Omics Integration Services
  5. 2.2 Global Integrated Multi-Omics Services Market Size by Type
  6. 2.2.1 Global Integrated Multi-Omics Services Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Integrated Multi-Omics Services Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Integrated Multi-Omics Services Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Integrated Multi-Omics Services Market Size by Regions
  10. 2.3.1 North America Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Integrated Multi-Omics Services Market Size Breakdown by Type (2021-2026)
3 Integrated Multi-Omics Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Disease Research
  3. 3.1.2 Precision Medicine
  4. 3.1.3 Crop Breeding
  5. 3.1.4 Environmental Microbial Monitoring
  6. 3.1.5 Others
  7. 3.2 Global Integrated Multi-Omics Services Market Size by Application
  8. 3.2.1 Global Integrated Multi-Omics Services Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Integrated Multi-Omics Services Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Integrated Multi-Omics Services Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Integrated Multi-Omics Services Market Size by Regions
  12. 3.3.1 North America Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Integrated Multi-Omics Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Integrated Multi-Omics Services Industry Trends
  2. 4.2 Integrated Multi-Omics Services Industry Drivers
  3. 4.3 Integrated Multi-Omics Services Industry Opportunities and Challenges
  4. 4.4 Integrated Multi-Omics Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Integrated Multi-Omics Services Revenue (2021-2026)
  2. 5.2 Global Integrated Multi-Omics Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Integrated Multi-Omics Services Key Company Headquarters & Area Served
  4. 5.4 Global Integrated Multi-Omics Services Company, Product Type & Application
  5. 5.5 Global Integrated Multi-Omics Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Integrated Multi-Omics Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Integrated Multi-Omics Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Integrated Multi-Omics Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Azenta Life Sciences
  2. 6.1.1 Azenta Life Sciences Company Information
  3. 6.1.2 Azenta Life Sciences Business Overview
  4. 6.1.3 Azenta Life Sciences Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Azenta Life Sciences Integrated Multi-Omics Services Product Portfolio
  6. 6.1.5 Azenta Life Sciences Recent Developments
  7. 6.2 Eurofins
  8. 6.2.1 Eurofins Company Information
  9. 6.2.2 Eurofins Business Overview
  10. 6.2.3 Eurofins Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eurofins Integrated Multi-Omics Services Product Portfolio
  12. 6.2.5 Eurofins Recent Developments
  13. 6.3 Source BioScience
  14. 6.3.1 Source BioScience Company Information
  15. 6.3.2 Source BioScience Business Overview
  16. 6.3.3 Source BioScience Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Source BioScience Integrated Multi-Omics Services Product Portfolio
  18. 6.3.5 Source BioScience Recent Developments
  19. 6.4 Psomagen
  20. 6.4.1 Psomagen Company Information
  21. 6.4.2 Psomagen Business Overview
  22. 6.4.3 Psomagen Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Psomagen Integrated Multi-Omics Services Product Portfolio
  24. 6.4.5 Psomagen Recent Developments
  25. 6.5 Tempus
  26. 6.5.1 Tempus Company Information
  27. 6.5.2 Tempus Business Overview
  28. 6.5.3 Tempus Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Tempus Integrated Multi-Omics Services Product Portfolio
  30. 6.5.5 Tempus Recent Developments
  31. 6.6 Evotec
  32. 6.6.1 Evotec Company Information
  33. 6.6.2 Evotec Business Overview
  34. 6.6.3 Evotec Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Evotec Integrated Multi-Omics Services Product Portfolio
  36. 6.6.5 Evotec Recent Developments
  37. 6.7 Crown Bioscience
  38. 6.7.1 Crown Bioscience Company Information
  39. 6.7.2 Crown Bioscience Business Overview
  40. 6.7.3 Crown Bioscience Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Crown Bioscience Integrated Multi-Omics Services Product Portfolio
  42. 6.7.5 Crown Bioscience Recent Developments
  43. 6.8 Sapient
  44. 6.8.1 Sapient Company Information
  45. 6.8.2 Sapient Business Overview
  46. 6.8.3 Sapient Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sapient Integrated Multi-Omics Services Product Portfolio
  48. 6.8.5 Sapient Recent Developments
  49. 6.9 Bruker Spatial Biology CRO Services
  50. 6.9.1 Bruker Spatial Biology CRO Services Company Information
  51. 6.9.2 Bruker Spatial Biology CRO Services Business Overview
  52. 6.9.3 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product Portfolio
  54. 6.9.5 Bruker Spatial Biology CRO Services Recent Developments
  55. 6.10 Advanced Cell Diagnostics (ACD)
  56. 6.10.1 Advanced Cell Diagnostics (ACD) Company Information
  57. 6.10.2 Advanced Cell Diagnostics (ACD) Business Overview
  58. 6.10.3 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product Portfolio
  60. 6.10.5 Advanced Cell Diagnostics (ACD) Recent Developments
  61. 6.11 Panome Bio
  62. 6.11.1 Panome Bio Company Information
  63. 6.11.2 Panome Bio Business Overview
  64. 6.11.3 Panome Bio Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Panome Bio Integrated Multi-Omics Services Product Portfolio
  66. 6.11.5 Panome Bio Recent Developments
  67. 6.12 RayBiotech
  68. 6.12.1 RayBiotech Company Information
  69. 6.12.2 RayBiotech Business Overview
  70. 6.12.3 RayBiotech Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 RayBiotech Integrated Multi-Omics Services Product Portfolio
  72. 6.12.5 RayBiotech Recent Developments
  73. 6.13 Metware Biotechnology
  74. 6.13.1 Metware Biotechnology Company Information
  75. 6.13.2 Metware Biotechnology Business Overview
  76. 6.13.3 Metware Biotechnology Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Metware Biotechnology Integrated Multi-Omics Services Product Portfolio
  78. 6.13.5 Metware Biotechnology Recent Developments
  79. 6.14 HaploX
  80. 6.14.1 HaploX Company Information
  81. 6.14.2 HaploX Business Overview
  82. 6.14.3 HaploX Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 HaploX Integrated Multi-Omics Services Product Portfolio
  84. 6.14.5 HaploX Recent Developments
  85. 6.15 Creative Proteomics
  86. 6.15.1 Creative Proteomics Company Information
  87. 6.15.2 Creative Proteomics Business Overview
  88. 6.15.3 Creative Proteomics Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Creative Proteomics Integrated Multi-Omics Services Product Portfolio
  90. 6.15.5 Creative Proteomics Recent Developments
  91. 6.16 CD Genomics
  92. 6.16.1 CD Genomics Company Information
  93. 6.16.2 CD Genomics Business Overview
  94. 6.16.3 CD Genomics Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 CD Genomics Integrated Multi-Omics Services Product Portfolio
  96. 6.16.5 CD Genomics Recent Developments
  97. 6.17 Omics Empower
  98. 6.17.1 Omics Empower Company Information
  99. 6.17.2 Omics Empower Business Overview
  100. 6.17.3 Omics Empower Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Omics Empower Integrated Multi-Omics Services Product Portfolio
  102. 6.17.5 Omics Empower Recent Developments
  103. 6.18 Cmbio
  104. 6.18.1 Cmbio Company Information
  105. 6.18.2 Cmbio Business Overview
  106. 6.18.3 Cmbio Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Cmbio Integrated Multi-Omics Services Product Portfolio
  108. 6.18.5 Cmbio Recent Developments
  109. 6.19 Dalton Bioanalytics
  110. 6.19.1 Dalton Bioanalytics Company Information
  111. 6.19.2 Dalton Bioanalytics Business Overview
  112. 6.19.3 Dalton Bioanalytics Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Dalton Bioanalytics Integrated Multi-Omics Services Product Portfolio
  114. 6.19.5 Dalton Bioanalytics Recent Developments
  115. 6.20 General Metabolics
  116. 6.20.1 General Metabolics Company Information
  117. 6.20.2 General Metabolics Business Overview
  118. 6.20.3 General Metabolics Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 General Metabolics Integrated Multi-Omics Services Product Portfolio
  120. 6.20.5 General Metabolics Recent Developments
  121. 6.21 Signios Bio
  122. 6.21.1 Signios Bio Company Information
  123. 6.21.2 Signios Bio Business Overview
  124. 6.21.3 Signios Bio Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Signios Bio Integrated Multi-Omics Services Product Portfolio
  126. 6.21.5 Signios Bio Recent Developments
  127. 6.22 Source Genomics
  128. 6.22.1 Source Genomics Company Information
  129. 6.22.2 Source Genomics Business Overview
  130. 6.22.3 Source Genomics Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Source Genomics Integrated Multi-Omics Services Product Portfolio
  132. 6.22.5 Source Genomics Recent Developments
  133. 6.23 Genechem
  134. 6.23.1 Genechem Company Information
  135. 6.23.2 Genechem Business Overview
  136. 6.23.3 Genechem Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Genechem Integrated Multi-Omics Services Product Portfolio
  138. 6.23.5 Genechem Recent Developments
  139. 6.24 BGI Genomics
  140. 6.24.1 BGI Genomics Company Information
  141. 6.24.2 BGI Genomics Business Overview
  142. 6.24.3 BGI Genomics Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 BGI Genomics Integrated Multi-Omics Services Product Portfolio
  144. 6.24.5 BGI Genomics Recent Developments
  145. 6.25 OE Biotech
  146. 6.25.1 OE Biotech Company Information
  147. 6.25.2 OE Biotech Business Overview
  148. 6.25.3 OE Biotech Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 OE Biotech Integrated Multi-Omics Services Product Portfolio
  150. 6.25.5 OE Biotech Recent Developments
  151. 6.26 BMKGENE
  152. 6.26.1 BMKGENE Company Information
  153. 6.26.2 BMKGENE Business Overview
  154. 6.26.3 BMKGENE Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 BMKGENE Integrated Multi-Omics Services Product Portfolio
  156. 6.26.5 BMKGENE Recent Developments
  157. 6.27 Majorbio
  158. 6.27.1 Majorbio Company Information
  159. 6.27.2 Majorbio Business Overview
  160. 6.27.3 Majorbio Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Majorbio Integrated Multi-Omics Services Product Portfolio
  162. 6.27.5 Majorbio Recent Developments
  163. 6.28 Wayen Biotechnologies
  164. 6.28.1 Wayen Biotechnologies Company Information
  165. 6.28.2 Wayen Biotechnologies Business Overview
  166. 6.28.3 Wayen Biotechnologies Integrated Multi-Omics Services Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 Wayen Biotechnologies Integrated Multi-Omics Services Product Portfolio
  168. 6.28.5 Wayen Biotechnologies Recent Developments
7 North America
  1. 7.1 North America Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Integrated Multi-Omics Services Market Size by Country (2021-2026)
  3. 7.3 North America Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Integrated Multi-Omics Services Market Size by Country (2021-2026)
  3. 8.3 Europe Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Integrated Multi-Omics Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Integrated Multi-Omics Services Market Size by Country (2021-2026)
  3. 10.3 South America Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Integrated Multi-Omics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Integrated Multi-Omics Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Integrated Multi-Omics Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research